Checkmate Pharmaceuticals Earning Date (CMPI)

USA |NASDAQ |USD

CMPI Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 28, 2022 Dec 2021 $-0.72 $-0.69 $-0.63
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 28, 2022 Dec 2021 $0.00 - $0.00

Checkmate Pharmaceuticals's next earnings date is Monday, Mar 28, 2022 for the fiscal quarter ending Dec 2021.

CMPI Earnings Date & History Chart

CMPI Earnings & Revenue Forecast

CMPI Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-0.72 $-0.76 $-0.67
Mar 2022 1 $-0.82 $-0.82 $-0.82
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $-2.94 $-2.98 $-2.89
Dec 2022 3 $-2.74 $-3.09 $-2.20

CMPI Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 0 $-0.75 $-0.75 $-0.74
Mar 2022 0 / 1 $-0.81 $-0.81 $-0.80
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 2 / 0 $-2.99 $-2.99 $-2.86
Dec 2022 0 / 1 $-2.73 $-2.73 $-2.67

CMPI Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Mar 2022 1 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 3 $0.00 $0.00 $0.00
Dec 2022 3 $0.00 $0.00 $0.00

CMPI Earnings Date & Revenue History

CMPI Earnings History

|
Show More
Show More

CMPI Revenue History

|
Show More
Show More

Checkmate Pharmaceuticals Next Earnings Date & Report

CMPI Next Earnings Date & Report Preview: Dec 2021 (FQ)

CMPI's next earnings date is Monday, Mar 28, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 3 analysts, the average EPS estimation for Checkmate Pharmaceuticals's next quarterly earnings is $-0.72, with a low EPS estimation of $-0.76, and a high estimation of $-0.67.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 0 downward. The EPS 1 month trend is $-0.75, the last 2 month trend is $-0.75, and the 3 month trend is $-0.74.

Based on 3 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Checkmate Pharmaceuticals Previous Earnings Dates & Reports

CMPI Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Checkmate Pharmaceuticals's previous earnings date was Nov 12, 2021 for its fiscal quarter ended Sep 30, 2021.

CMPI's earnings per share (EPS) was $-0.69, beating the consensus analysts forecast of $-0.71 by 3.27%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -21.59%, and higher than the same period a year before (Sep 2020) by -17.86%.

The company reported a net income of $-14.97M.

Free cash flow for the quarter was $-43.72M , compared to $-15.77M last quarter and $-11.38M a year before.

CMPI Previous Earnings Date & Report Recap: Dec 2020 (FY)

Checkmate Pharmaceuticals's previous annual earnings date was Mar 29, 2021 for its fiscal year ended Dec 31, 2020.

CMPI's earnings per share (EPS) was $-8.84.

Revenues were $0.00.

The company reported a net income of $-36.91M.

Checkmate Pharmaceuticals reported a free cash flow of $-38.11M for its fiscal year, compared to $-26.85M a year ago.